首页> 美国卫生研究院文献>International Scholarly Research Notices >In Vitro Antimycobacterial Activity of Pakistani Beri Honey Using BACTEC MGIT 960
【2h】

In Vitro Antimycobacterial Activity of Pakistani Beri Honey Using BACTEC MGIT 960

机译:使用BACTEC MGIT 960的巴基斯坦Beri蜂蜜的体外抗分枝杆菌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Tuberculosis (TB) is a chronic bacterial disease. Mycobacterium tuberculosis, being the leading member of the MTB complex, is the main cause of tuberculosis worldwide. Tuberculosis is managed with combination of drugs: streptomycin, isoniazid, rifampicin, ethambutol, and pyrazinamide. Over the recent past years resistance against first line antituberculous drugs has emerged rapidly throughout the world resulting in MDR strains. The new threat in the management of MDR-TB is the development of resistance against second line drugs: aminoglycosides, polypeptides, fluoroquinolones, and thioamides. Multidrug resistant (MDR) and extensively drug resistant TB (XDR) strains have become a major concern to control TB particularly in the developing countries. The need of the hour is to look for new modalities having antimycobacterial activity. Honey has been well known for its antibacterial activity. We intended to explore its antimycobacterial activity against MDR-TB. Objective. The objective of this study was to determine whether Pakistani Beri honey has any antimycobacterial activity. Method. The study was conducted in the Department of Microbiology, University of Health Sciences, Lahore. Clinical isolates (n = 21) of MDR-MTB were evaluated for their susceptibility to Beri honey. The isolates were provided, courtesy of Pakistan Medical Research Council. These isolates were identified by MTBc ID test (Becton & Dickinson) and further tested for their antimycobacterial activity using Beri honey. The honey was tested at the following concentrations (v/v): 1%, 2%, 3%, 4%, and 5% in MGIT 960. Growth controls were also inoculated with each isolate (growth control has no concentration of honey, only containing growth of isolate). Results. MDR-TB isolates (n = 21) were tested; 3 (14%) isolates were susceptible at 1% v/v honey, while at 2% v/v of honey 18 (86%) isolates were found to be susceptible. All the 21 isolates (n = 21) were susceptible at 3% v/v of honey. Conclusion. The present study clearly demonstrates that Pakistani Beri honey possesses significant antimycobacterial activity in vitro. The antimycobacterial activity of Pakistani Beri honey may, therefore, be exploited in an appropriate mouse model.
机译:背景。结核病(TB)是一种慢性细菌性疾病。结核分枝杆菌是MTB复合体的主要成员,是全球结核病的主要原因。结核病可通过以下药物组合治疗:链霉素,异烟肼,利福平,乙胺丁醇和吡嗪酰胺。在最近几年中,对一线抗结核药物的耐药性在世界范围内迅速出现,导致了耐多药菌株。耐多药结核病管理的新威胁是对二线药物耐药性的发展:氨基糖苷类,多肽,氟喹诺酮类和硫代酰胺类。尤其在发展中国家,耐多药(MDR)和广泛耐药性TB(XDR)菌株已成为控制结核的主要问题。一个小时的需求是寻找具有抗分枝杆菌活性的新形式。蜂蜜以其抗菌活性而闻名。我们打算探索其对耐多药结核病的抗分枝杆菌活性。目的。这项研究的目的是确定巴基斯坦Beri蜂蜜是否具有抗分枝杆菌活性。方法。该研究在拉合尔健康科学大学微生物学系进行。评估了MDR-MTB的临床分离株(n = 21)对Beri蜂蜜的敏感性。这些分离株是由巴基斯坦医学研究理事会提供的。这些分离物通过MTBc ID测试(Becton&Dickinson)进行鉴定,并使用Beri蜂蜜进一步测试其抗分枝杆菌活性。对蜂蜜进行了以下浓度(v / v)测试:在MGIT 960中分别为1%,2%,3%,4%和5%。每种分离株也接种了生长对照(生长对照没有蜂蜜浓度,仅包含隔离株的生长)。结果。测试了耐多药结核病菌株(n = 21);蜂蜜中1%v / v的菌群中有3个(14%)分离株,而蜂蜜中2%v / v的菌群则有18个(86%)分离株易感。所有21个分离株(n = 21)都以3%v / v的蜂蜜敏感。结论。本研究清楚地表明,巴基斯坦贝里蜂蜜在体外具有显着的抗分枝杆菌活性。因此,可以在适当的小鼠模型中利用巴基斯坦Beri蜂蜜的抗分枝杆菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号